Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Atherosclerosis Progression in HIV
NCT01813357Phase 4Completed
- Start
- Jul 2013
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in atherosclerosis comparing Rosuvastatin with Placebo (2 arms). Primary endpoint: Progression of Carotid Intima Media Thickness at 96 weeks. Started Jul 2013; status: completed.
02
Drugs
rosuvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT01813357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01813357.